These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 6493580)

  • 1. Comparison of the in vitro activity of azlocillin and carbenicillin against 856 clinical bacterial isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1984 Jun; 7(1):13-9. PubMed ID: 6493580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticarcillin: a collaborative in vitro comparison with carbenicillin against over 9,000 clinical bacterial isolates.
    Fuchs PC; Gavan TL; Gerlach EH; Jones RN; Barry AL; Thornsberry C
    Am J Med Sci; 1977; 274(3):255-63. PubMed ID: 610415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibacterial spectrum of mezlocillin and MIC/disc correlations (author's transl)].
    Soussy CJ; Le Van Thoi J; Duval J
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):309-13. PubMed ID: 6460965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimum inhibitory concentration determinations for various antimicrobial agents against 1570 bacterial isolates from turkey poults.
    Salmon SA; Watts JL
    Avian Dis; 2000; 44(1):85-98. PubMed ID: 10737648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods.
    Moody JA; Gerding DN; Peterson LR
    Am J Med; 1987 Apr; 82(4A):44-54. PubMed ID: 3107380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azlocillin: in vitro studies of a new semisynthetic penicillin.
    Stewart D; Bodey GP
    Antimicrob Agents Chemother; 1977 May; 11(5):865-70. PubMed ID: 18083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX; Jules K; Neu HC
    Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro antibacterial activity of cefmenoxime (SCE 1365)].
    Brun Y; Forey F; Coulet M; Fleurette J; Bryskier A
    Pathol Biol (Paris); 1983 May; 31(5):343-6. PubMed ID: 6312394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative activity of cefsulodin on Pseudomonas aeruginosa, Acinetobacter and Enterobacteriaceae (author's transl)].
    Courtieu AL; Drugeon HB; Bryskier A; Chung SS; Reynaud A
    Pathol Biol (Paris); 1982 Jun; 30(6):432-9. PubMed ID: 6810287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of a new semisynthetic cephalosporin: cefoperazone.
    Auckenthaler R; Waldvogel FA
    Clin Ther; 1980; 3(Spec Issue):89-97. PubMed ID: 6446401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of carbenicillin against Pseudomonas using the disc diffusion method.
    Washington JA; Hall MM; Fausch CJ; Brackin KL
    Mayo Clin Proc; 1973 Oct; 48(10):718-21. PubMed ID: 4200876
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative antimicrobial activity of lomefloxacin, norfloxacin, ofloxacin, ciprofloxacin and enoxacin against > 500 bacterial isolates.
    Ismaeel NA; Tayeb OS
    Microbios; 1993; 74(300):147-54. PubMed ID: 8396196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.
    López-Brea M; Alarcón T; Domingo D; Díaz-Regañón J
    J Antimicrob Chemother; 2008 Jan; 61(1):139-42. PubMed ID: 17965421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in-vitro activity of azlocillin: a community hospital study of 1900 clinical isolates.
    Parry MF
    J Antimicrob Chemother; 1983 May; 11 Suppl B():15-20. PubMed ID: 6619025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa.
    Sobel JD; Levison ME; Kaye D
    Infection; 1980; 8(3):121-2. PubMed ID: 6448229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the in vitro activity of norfloxacin and other drugs on amoxicillin-resistant uropathogenic isolates.
    Piccolomini R; Allocati N; Catamo G
    Chemioterapia; 1984 Jun; 3(3):167-72. PubMed ID: 6241505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.